ASU 2024-03: New Expense Transparency for Technology & Life Sciences Companies

Three Questions to Ask About New Tax Transparency Regimes

The new data disclosures will draw significant attention in 2026 and beyond. However, because the data is rooted in financial accounting con

Navigating the Tax Transparency Landscape

Join us on Wednesday, July 29 for an informational webinar exploring the challenges posed by recent company tax disclosures, including their

China Compliance Update: Life Sciences — Spring 2026

In 2026, Chinese regulators have continued their focus on anti-corruption enforcement in the life sciences industry. In addition to long-sta

Innovative Insights: Legal Updates in Life Sciences

State AGs Expand ‘Affordability’ Focus, Increasing Potential Scrutiny of Pricing and Competition

State attorneys general have turned their focus to “affordability” concerns in recent months, including California announcing an Affordabili

Recent moves of note in and around the biotech and pharma industries

Recent moves of note in and around the biotech and pharma industries